List of insiders holdings for Galera Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Schneid Yair 10% Owner | 2024-05-16 10:26:17 | 10,823,610 0 | 10,823,610 | Form 13G |
| Soffer Rochel ALPHA PHARMA Investments LLC 10% Owner | 2024-05-16 10:26:45 | 3,178,137 2,750,000 | 5,928,137 | Form 3 |
| New Enterprise Associates 14 L.P. Sonsini Peter W. KERINS PATRICK J NEA Partners 14 L.P. NEA 14 GP LTD BARRIS PETER J BASKETT FOREST Florence Anthony A. Jr. MOTT DAVID M SANDELL SCOTT D 10% Owner | 2020-02-13 10:50:02 | 4,358,042 0 | 4,358,042 | Form 13G |
| Novo Holdings A/S 10% Owner | 2023-06-28 16:19:56 | 2,100,000 0 | 2,100,000 | Form 13G |
| Blackstone Clarus GP L.P. Blackstone Clarus GP L.L.C. Blackstone Holdings II L.P. Blackstone Holdings I/II GP L.L.C. Blackstone Group Inc Blackstone Group Management L.L.C. SCHWARZMAN STEPHEN A 10% Owner | 2020-02-14 15:29:03 | 1,680,632 0 | 1,680,632 | Form 13G |
| Novartis Bioventures Ltd NOVARTIS AG Former 10% Owner | 2022-02-11 16:30:53 | 476,085 0 | 476,085 | Form 13G |
| Sorensen Mel President and CEO | 2024-08-20 16:45:02 | 265,029 0 | 265,029 | Form 4 |
| Keene Jeffrey 10% Owner | 2019-11-06 17:27:59 | 172,238 0 | 172,238 | Form 3 |
| Beardsley Robert A Chief Operating Officer | 2023-02-28 19:06:09 | 135,000 0 | 135,000 | Form 4 |
| Stacey Jennifer Evans See Remarks | 2023-02-28 18:56:05 | 135,000 0 | 135,000 | Form 4 |
| Clarus IV-A L.P. Clarus IV-B L.P. Clarus IV-C L.P. Clarus IV-D L.P. Clarus IV GP L.P. 10% Owner | 2019-11-14 17:00:59 | 0 130,444 | 130,444 | Form 4 |
| Fratamico Arthur Chief Business Officer | 2021-01-28 16:05:09 | 75,000 0 | 75,000 | Form 4 |
| HOLMLUND JON T Chief Medical Officer | 2022-03-02 16:05:46 | 75,000 0 | 75,000 | Form 4 |
| Matthes Catherine L. 10% Owner | 2019-11-06 17:24:24 | 8,503 66,184 | 74,687 | Form 3 |
| Riley Dennis Chief Scientific Officer | 2020-02-04 18:00:43 | 74,435 0 | 74,435 | Form 4 |
| POWELL MICHAEL Director | 2023-06-16 16:15:35 | 64,000 0 | 64,000 | Form 4 |
| Buckler Regina A. 10% Owner | 2019-11-06 17:28:54 | 62,254 0 | 62,254 | Form 3 |
| Wood Brian 10% Owner | 2019-11-06 17:32:34 | 62,137 0 | 62,137 | Form 3 |
| Brill Jeffrey 10% Owner | 2019-11-06 17:31:51 | 62,137 0 | 62,137 | Form 3 |
| Schall Otto 10% Owner | 2019-11-06 17:20:10 | 55,137 0 | 55,137 | Form 3 |
| Kennedy Eugene P. Chief Medical Officer | 2023-02-28 18:57:34 | 55,000 0 | 55,000 | Form 4 |
| Sussman Joel F. Chief Accounting Officer | 2021-01-28 16:05:16 | 50,000 0 | 50,000 | Form 4 |
| LOKAY KEVIN G Director | 2023-06-16 16:15:13 | 48,000 0 | 48,000 | Form 4 |
| Ross Stephen A 10% Owner | 2019-11-06 17:21:58 | 46,622 0 | 46,622 | Form 3 |
| West Linda Director | 2023-07-05 16:11:02 | 23,382 0 | 23,382 | Form 4 |
| Alleva Lawrence M Director | 2023-07-05 16:19:45 | 22,762 0 | 22,762 | Form 4 |
| Fuller Jason Director | 2019-11-08 19:49:13 | 19,776 0 | 19,776 | Form 4 |
| Bachleda Mark Chief Commercial Officer | 2023-03-20 16:05:17 | 11,000 0 | 11,000 | Form 4 |
| Degnan Chris Chief Financial Officer | 2023-03-14 08:30:09 | 10,000 0 | 10,000 | Form 4 |
| Cunningham Emmett Director | 2023-06-16 16:15:10 | 0 0 | 0 | Form 4 |
| Altamont Pharmaceutical Holdings LLC Pearson Mark E. 10% Owner | 2024-04-03 08:08:38 | 0 0 | 0 | Form 13G |
| Sofinnova Venture Partners IX L.P. Sofinnova Management IX L.L.C. POWELL MICHAEL HEALY JAMES Mehra Anand 10% Owner | 2024-02-20 18:57:58 | 0 0 | 0 | Form 13D |